NEW YORK ( TheStreet) -- Shares of Velti (Nasdaq: VELT) have taken a tremendous swing upward. The stock is trading at $7.26 as of 12:41 p.m. ET, 22.8% above Thursday's closing price of $5.91. Volume is at 3.4 million, 2.9 times the daily average of 1.2 million. Velti has a market cap of $359.1 million and is part of the technology sector and computer software & services industry. Shares are down 13.1% year to date as of the close of trading on Thursday. Velti plc engages in the provision of mobile marketing and advertising technology and solutions for brands, advertising agencies, mobile operators, and media companies in Europe, the Americas, Asia, and Africa. TheStreet Ratings rates Velti as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in net income. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. You can view the full Velti Ratings Report. See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Markets
Replay: Jim Cramer on Earnings Season, China and Amazon Prime Day
Jim Cramer's breaking down what he expects from earnings season, China's slowing growth, and Amazon's Prime day sale.
Dow, S&P 500 and Nasdaq End at Record Closes as Earnings Season Kicks Off
All three stock indexes struggled to a record close Monday as investors gear up for earnings season.
Newt Gingrich on the U.S.-China Trade Talks, Biotech and Advice for Investors
Newt Gingrich weighs in on the U.S.-China trade deal, President Trump's social media presence, his focus on gene therapy and his advice for investors.
JPMorgan Is Bullish on the S&P 500's Second-Half Performance
JPMorgan raised its S&P price target to 3,200 from 3,000.